Precision cancer therapy, grounded in evidence
Quark predicts drug response from genomic mutations with a 6.36B-parameter transformer — 100% cancer-type accuracy and 96.15% drug-response accuracy, calibrated against 1,227 CIViC clinical-evidence entries.
Platform capabilities
An integrated clinical workspace spanning prediction, simulation, imaging, and compliance.
Digital Patient Twins
Genomic, proteomic, and imaging data integrated per patient for personalized treatment modeling.
3D Drug Simulation
Visualize and simulate chemotherapy treatments at the molecular level before administration.
Physics Engine
Deterministic cancer-spread modeling with conservation laws and temporal dynamics.
Medical Imaging
BiomedCLIP-powered pathology image classification and tissue analysis.
CRISPR Protocol Generator
AI-designed therapeutic gene-editing protocols with Ensembl gene lookup.
CAR-T Cell Designer
Multi-antigen targeting with AI-optimized immune-cell engineering protocols.
Drug Interaction Checker
Real-time interaction analysis from a clinical database for safer prescribing.
Analytics Dashboard
Patient cohort analytics and visualizations powered by real clinical data.
FDA Compliance
Regulatory tracking for clinical-trial readiness and submission preparation.
Lab Results
Laboratory ordering, tracking, and result management with trend analysis.
Clinical Encounters
Encounter scheduling, documentation, and FHIR/DICOM-compliant records.